Teva Neuroscience files suit against Apotex over one patent related to a method of treating a subject for Parkinson’s disease which comprises administering to the subject an amount of R(+)-N-propargyl-1-aminoindan. 5/27, District of New Jersey, 2:2011cv03076.
Access to the full article is currently available to RPX members only. Please contact us if you need further information.
